Rep. Maria Elvira Salazar Buys UnitedHealth Group Incorporated (NYSE:UNH) Stock

Posted by Bonnie Powley on May 12th, 2026

Representative Maria Elvira Salazar (Republican-Florida) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on May 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on April 22nd. The trade occurred in the Representative’s “UBS BROKERAGE ACCOUNT” account.

Representative Maria Elvira Salazar also recently made the following trade(s):

Purchased $15,001 – $50,000 in shares of Carrier Global (NYSE:CARR) on 5/1/2026.
Purchased $1,001 – $15,000 in shares of Carrier Global (NYSE:CARR) on 5/1/2026.
Purchased $1,001 – $15,000 in shares of United Rentals (NYSE:URI) on 4/24/2026.
Purchased $1,001 – $15,000 in shares of Sherwin-Williams (NYSE:SHW) on 4/20/2026.
Purchased $15,001 – $50,000 in shares of Sherwin-Williams (NYSE:SHW) on 4/20/2026.
Purchased $15,001 – $50,000 in shares of Microsoft (NASDAQ:MSFT) on 4/17/2026.
Sold $15,001 – $50,000 in shares of Amgen (NASDAQ:AMGN) on 4/17/2026.
Purchased $1,001 – $15,000 in shares of Voyager Technologies (NYSE:VOYG) on 4/14/2026.
Purchased $15,001 – $50,000 in shares of Marvell Technology (NASDAQ:MRVL) on 4/6/2026.
Purchased $15,001 – $50,000 in shares of Salesforce (NYSE:CRM) on 4/6/2026.

UnitedHealth Group Trading Up 0.5%

NYSE UNH traded up $1.74 during trading hours on Tuesday, reaching $386.18. The company’s stock had a trading volume of 1,407,699 shares, compared to its average volume of 9,258,853. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $386.49. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80. The stock has a market cap of $350.70 billion, a P/E ratio of 29.17, a P/E/G ratio of 1.64 and a beta of 0.64. The firm has a fifty day simple moving average of $308.40 and a 200-day simple moving average of $317.22.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. The company had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. UnitedHealth Group’s revenue was up 2.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.3%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s payout ratio is 66.77%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on UNH. Raymond James Financial raised shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 target price for the company in a research report on Wednesday, April 1st. Oppenheimer increased their price objective on shares of UnitedHealth Group from $385.00 to $405.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Piper Sandler reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Tuesday, January 27th. Erste Group Bank raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, April 27th. Finally, UBS Group decreased their target price on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $378.88.

Read Our Latest Analysis on UNH

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at $6,320,775. The trade was a 4.30% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.28% of the company’s stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

Positive Sentiment: Optum Rx introduced an industry-first transparent pharmacy care model that replaces volume- and drug-price-linked compensation with a fee-based structure, which could improve clarity, align incentives with customers, and support longer-term earnings visibility. Optum Rx Introduces Industry’s First Transparent Pharmacy Care Model
Positive Sentiment: Analyst commentary from Zacks highlighted UnitedHealth among top research picks, reflecting continued focus on the company’s growth drivers and earnings outlook. The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
Neutral Sentiment: Additional market coverage from Yahoo Finance echoed the same analyst focus on UnitedHealth’s growth drivers, but did not introduce a new fundamental catalyst. The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
Neutral Sentiment: A broader market report on clinical informatics pointed to long-term healthcare technology growth, which is not a direct catalyst for UnitedHealth but underscores supportive industry trends. Latest Global Clinical Informatics Market Size/Share Worth USD 962.41 Billion by 2035…

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in UNH. Norges Bank bought a new position in shares of UnitedHealth Group in the 4th quarter worth $4,376,167,000. Capital Research Global Investors lifted its stake in shares of UnitedHealth Group by 126.9% in the third quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock valued at $4,503,419,000 after buying an additional 7,293,009 shares in the last quarter. Capital World Investors raised its holdings in shares of UnitedHealth Group by 18.8% in the 3rd quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock worth $7,516,107,000 after acquiring an additional 3,439,182 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in UnitedHealth Group by 141.9% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 4,109,029 shares of the healthcare conglomerate’s stock valued at $1,356,432,000 after purchasing an additional 2,410,128 shares during the last quarter. Finally, Cardano Risk Management B.V. raised its stake in shares of UnitedHealth Group by 864.4% in the fourth quarter. Cardano Risk Management B.V. now owns 2,523,700 shares of the healthcare conglomerate’s stock worth $833,099,000 after purchasing an additional 2,262,006 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

About Representative Salazar

Maria Elvira Salazar (Republican Party) is a member of the U.S. House, representing Florida’s 27th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.

Salazar (Republican Party) ran for re-election to the U.S. House to represent Florida’s 27th Congressional District. She won in the general election on November 5, 2024.

Maria Elvira Salazar was born in Miami, Florida, and lives in Coral Gables, Florida. Salazar earned an undergraduate degree from the University of Miami in 1983 and a graduate degree from Harvard University in 1995. Her career experience includes working as a television journalist, reporter, and news anchor.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.